Market mapping and landscape analysis of human rabies biologicals in India
Background: Rabies vaccines and immunoglobulins are lifesaving in humans following animal exposures. These biologicals should continuously be available throughout the year to prevent and eliminate human rabies by 2030. Objectives: The present study aimed at assessing availability of different kinds...
Main Authors: | Mysore Kalappa Sudarshan, Doddabele Hanumanthaiah Ashwath Narayana, Mahendra Bangalore Jayakrishnappa |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Indian Journal of Public Health |
Subjects: | |
Online Access: | http://www.ijph.in/article.asp?issn=0019-557X;year=2019;volume=63;issue=5;spage=37;epage=43;aulast=Sudarshan |
Similar Items
-
Background paper for developing a policy for the use of rabies biologicals and vaccination of humans in India
by: Mysore Kalappa Sudarshan, et al.
Published: (2019-01-01) -
Appraisal of surveillance of human rabies and animal bites in seven states of India
by: Mysore Kalappa Sudarshan, et al.
Published: (2019-01-01) -
Assessing rabies-free status of Andaman, Nicobar, and Lakshadweep Islands, India
by: Shrikrishna Isloor, et al.
Published: (2019-01-01) -
Compliance to anti-rabies vaccination in post-exposure prophylaxis
by: Ravish Haradanahalli Shankaraiah, et al.
Published: (2015-01-01) -
Defining the volume of rabies immunoglobulins/ rabies monoclonal antibodies requirement for wound infiltration of category III animal exposures – an exploratory study
by: Ravish S. Haradanhalli, et al.
Published: (2021-12-01)